基本信息:
- 专利标题： GLUCOCEREBROSIDE TREATMENT OF DISEASE
- 专利标题（中）：肝炎的治疗葡糖脑苷脂
- 申请号：EP04784642.3 申请日：2004-09-20
- 公开(公告)号：EP1675547A2 公开(公告)日：2006-07-05
- 发明人： ILAN, Yaron , MARGALIT, Maya , ZIMRAN, Ari
- 申请人： ENZO THERAPEUTICS, INC.
- 申请人地址： 9th floor, 527 Madison Avenue New York, NY 10022 US
- 专利权人： ENZO THERAPEUTICS, INC.
- 当前专利权人： ENZO THERAPEUTICS, INC.
- 当前专利权人地址： 9th floor, 527 Madison Avenue New York, NY 10022 US
- 代理机构： Breese Derambure Majerowicz
- 优先权： US675980 20030930
- 国际公布： WO2005032462 20050414
- 主分类号： A61K6/00
- IPC分类号： A61K6/00
摘要：
The present invention provides a method for the treatment of immune mediated or immune related diseases or disorders, infectious diseases, metabolic disorders and cancer in mammalian subjects. This method comprises the administration of a naturally occurring, mammalian intermediary metabolite or T cell receptor ligand, preferably a glucosylceramide, to a mammalian subject. In a preferred embodiment, such mammalian subjects are human beings.
公开/授权文献:
- EP1675547B1 Glucocerebroside treatment of hepatitis 公开/授权日：2013-03-06
IPC结构图谱:
| A | 人类生活必需 |
| --A61 | 医学或兽医学；卫生学 |
| ----A61K | 医用、牙科用或梳妆用的配制品 |
| ------A61K6/00 | 牙科制剂 |